BSE Live
Sep 29, 16:01Prev. Close
214.45
Open Price
214.50
Bid Price (Qty.)
218.15 (300)
Offer Price (Qty.)
228.00 (199)
NSE Live
Sep 29, 15:48Prev. Close
214.95
Open Price
215.04
Bid Price (Qty.)
219.00 (2990)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Jagsonpal Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 268.72 | 208.70 | 236.71 | 226.10 | 187.95 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 268.72 | 208.70 | 236.71 | 226.10 | 187.95 | |
Total Operating Revenues | 268.72 | 208.70 | 236.71 | 226.10 | 187.95 | |
Other Income | 8.19 | 9.28 | 5.73 | 3.34 | 4.39 | |
Total Revenue | 276.91 | 217.98 | 242.45 | 229.43 | 192.34 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 18.34 | 22.10 | 31.21 | 40.42 | 38.63 | |
Purchase Of Stock-In Trade | 80.22 | 53.98 | 57.59 | 49.75 | 36.86 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -2.13 | 3.90 | 4.30 | 5.61 | 5.28 | |
Employee Benefit Expenses | 64.13 | 48.49 | 56.42 | 57.68 | 53.98 | |
Finance Costs | 0.96 | 0.81 | 0.41 | 0.29 | 1.09 | |
Depreciation And Amortisation Expenses | 8.13 | 1.66 | 1.21 | 1.53 | 0.51 | |
Other Expenses | 57.08 | 56.40 | 53.04 | 46.84 | 34.11 | |
Total Expenses | 226.73 | 188.11 | 204.18 | 202.11 | 170.47 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 50.17 | 29.87 | 38.27 | 27.32 | 21.87 | |
Exceptional Items | 19.69 | 0.00 | -3.46 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 69.86 | 29.87 | 34.81 | 27.32 | 21.87 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 14.50 | 7.56 | 7.63 | 7.40 | 6.05 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | -0.15 | 0.46 | 0.33 | -1.23 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 14.50 | 7.41 | 8.09 | 7.73 | 4.81 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 | |
Profit/Loss From Continuing Operations | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 | |
Profit/Loss For The Period | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 8.26 | 8.49 | 10.20 | 7.48 | 6.51 | |
Diluted EPS (Rs.) | 8.22 | 8.46 | 10.20 | 7.48 | 6.51 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 13.10 | 0.00 | 10.48 | 2.62 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 125.00 | 100.00 | 100.00 | 80.00 | 20.00 |
05.09.2025
28.07.2025
JagsonpalPharma Standalone June 2025 Net Sales at Rs 75.61 crore, up 23.07% Y-o-Y
09.07.2025
07.05.2025
JagsonpalPharma Standalone March 2025 Net Sales at Rs 58.56 crore, up 34.66% Y-o-Y
28.07.2025
JagsonpalPharma Standalone June 2025 Net Sales at Rs 75.61 crore, up 23.07% Y-o-Y
07.05.2025
JagsonpalPharma Standalone March 2025 Net Sales at Rs 58.56 crore, up 34.66% Y-o-Y
24.01.2025
JagsonpalPharma Standalone December 2024 Net Sales at Rs 74.03 crore, up 56.72% Y-o-Y
25.10.2024
JagsonpalPharma Standalone September 2024 Net Sales at Rs 74.69 crore, up 29.16% Y-o-Y